Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Urethral Syndrome Treatment & Management

  • Author: Martha K Terris, MD, FACS; Chief Editor: Edward David Kim, MD, FACS  more...
 
Updated: Jan 21, 2015
 

Medical Care

The goal of treatment in urethral syndrome is to relieve the discomfort and urinary frequency. This often involves a trial-and-error approach that uses behavioral, dietary, and medical therapy. The urologist must gain the confidence of these patients and should provide assurance and encouragement throughout therapy.

Pharmacologic therapy is discussed in detail in Medication. Medications include the following:

  • Hormone replacement
  • Anesthetics
  • Antispasmodics
  • Tricyclic antidepressants (TCAs)
  • Muscle relaxants
  • Alpha-blockers

Behavioral therapy, including biofeedback, meditation, and hypnosis, has been used with some success. Biofeedback has the most promise in individuals whose symptoms are due to a failure to relax the pelvic musculature during voiding. Attempts at relaxation while undergoing electromyelography monitoring can help the patient retrain their muscles to allow them to void normally.

Dietary therapy is geared primarily at increasing urinary pH.

Palleschi and colleagues reported significant and comparable symptom improvement with the oral phytotherapeutic product Cistiquer and intravesical gentamicin plus betametasone in a randomized study of 60 women with urethral syndrome and trigonitis. The dropout rate and the incidence of infection were higher in the intravesical treatment group.[3]

Next

Surgical Care

Historically, the primary surgical procedure used to treat urethral syndrome has been urethral dilation. Previously a commonly used technique for practically all female urinary tract pain syndromes, urethral dilation is rarely performed in current practice. However, women with true urethral stenosis as the etiology of their symptoms experience significant improvement after urethral dilation.

The implantable InterStim system uses mild electrical stimulation of the sacral nerve (near the sacrum). These nerves provide the most distal common autonomic and somatic nerve supply to the pelvic floor, detrusor muscle, and lower gastrointestinal tract. In properly selected patients, InterStim therapy can dramatically reduce or eliminate symptoms.

Nd:YAG laser ablation of squamous metaplasia at the bladder neck-trigone has shown some promise in patients with urethral syndrome refractory to medical management and with findings of trigonitis. Success appears to depend on necrotic coagulation followed by reconstitution of normal functional epithelium.[4]

Previous
Next

Consultations

Most women with urethral syndrome–type symptoms initially present to a gynecologist; thus, most gynecologic abnormalities have been excluded as diagnostic possibilities before the patient reaches the urologist. However, if a female patient has not seen a gynecologist and concern exists that she may have a gynecologic abnormality as an etiology of her symptoms or as a separate disease entity, referral to a gynecologist is recommended.

The secondary psychological impact of chronic pain syndromes can be substantial. Consultation with a psychiatrist or pain-control specialist may help in management.

Any question of a previously undiagnosed neurological condition (eg, multiple sclerosis, Parkinson disease) should prompt a consultation with a neurologist.

A physical therapist experienced in biofeedback can provide support and relief to some patients with urethral syndrome.

Previous
Next

Diet

Intake of foods and liquids that are excreted as irritants in the urine may worsen symptoms.

Patients should avoid highly acidic foods. These typically include spicy foods, but a more complete, although not comprehensive, list is provided below. Food reactions can be extremely individualized. Some patients may find that some of these foods worsen their symptoms, while others do not. The most recommended approach is to initiate a bland diet, excluding all of the suspect foods; then, gradually reintroduce individual foods, one per week, while noting symptoms. If symptoms worsen upon introduction of a particular food, that food should be eliminated from the diet on a long-term basis.

Alcohol and other beverages that may worsen syndromes include the following:

  • Beer
  • Champagne
  • Liquor
  • Wine
  • Coffee (decaffeinated, regular)
  • Soda (eg, cola)
  • Tea (decaffeinated, regular, iced)

Condiments that may worsen syndromes include the following:

  • Barbecue sauce
  • Capers
  • Chutney
  • Cocktail sauce
  • Corn relish
  • Cranberry sauce
  • Horseradish
  • Hot pepper sauce
  • Ketchup
  • Mustard
  • Pickles
  • Relishes
  • Roasted peppers
  • Salsa
  • Sauerkraut
  • Sweet and sour sauce
  • Tartar sauce
  • Vinegar
  • Worcestershire sauce

Fruits that may worsen syndromes include the following:

  • Apples
  • Bananas
  • Cantaloupe
  • Grapefruit
  • Grapes
  • Kiwi
  • Lemon
  • Lime
  • Mango
  • Nectarines
  • Oranges
  • Peaches
  • Pears
  • Pineapple
  • Plums
  • Star fruit
  • Strawberries
  • Tomatoes (all varieties)

Juices that may worsen syndromes include the following:

  • Apple juice or cider
  • Cranberry-apple or cranberry-grape
  • Cranberry
  • Mixed fruit
  • Grape
  • Grapefruit
  • Guava
  • Lemon (eg, lemonade)
  • Mango
  • Papaya
  • Peach
  • Pear
  • Pineapple
  • Prune
  • Tamarind
  • Tomato

Salad dressings that may worsen syndromes include the following:

  • Bleu cheese
  • Caesar
  • French
  • Honey mustard
  • Italian
  • Poppy seed
  • Ranch
  • Thousand Island
  • Vinaigrette

Snacks that may worsen syndromes include the following:

  • Applesauce
  • Chocolate
  • Gelatin (eg, Jell-O)
  • Spicy crackers
  • Spicy nachos
  • Spicy potato chips

Vegetables that may worsen syndromes include the following:

  • Beets
  • Cabbage
  • Canned or jarred artichokes
  • Peppers (green, red)
  • Hot peppers (eg, jalapeño)

Miscellaneous foods that may worsen syndromes include the following:

  • Olive oil
  • Chili
  • Pizza sauce
  • Marinara sauce
  • Tomato sauce
  • Tomato soup

A diet high in vegetables, fruits, and dairy products reduces the acidity of urine. The Interstitial Cystitis (IC) Network has developed low-acid recipes specifically for patients with IC and urethral syndrome (see The IC Chef). Calcium glycerophosphate, marketed as Prelief, can be sprinkled over foods to reduce acidity. Dietary supplementation with sodium bicarbonate or potassium bicarbonate can provide relief for some patients.

Increased fluid intake is advisable. Because many drinks increase acidity, patients may be prone to dehydration. This also may be an attempt by the patient to decrease urinary frequency by decreasing urine output. In fact, more concentrated urine is more acidic and contains a higher concentration of irritants. Patients should be encouraged to drink plenty of fluid, specifically water.

Previous
Next

Activity

Exercise and massage programs that put patients in better control of their muscles can be very helpful.

  • Yoga and t'ai chi both emphasize balance, posture, and integrated movement that diminish tightness of the muscles. Through these activities, patients learn to better control and relax muscle groups and learn which muscle groups contribute to or improve their chronic pain.
    • In fact, to center the mind, t'ai chi uses a physical location in the lower abdomen/pelvis, close to the area of problems in urethral syndrome patients, called the Tan T'ien. From this state of attention develops the possibility to change, correct, and heal.
    • According to t'ai chi principles, the Tan T'ien, located approximately 2 inches below the navel and in the center of the pelvic area, is a body location that expresses the multifaceted principle that is referred to in t'ai chi as "center." The Tan T'ien is understood to be the true body center in a sense of balance, integration, and strength.
    • T'ai chi emphasizes the ability to place the focus of the mind in the Tan T'ien in order to improve movement skills by eliminating the poor movement habit of excessive upper-body emphasis (ie, head, shoulders, arms).
  • Myofascial therapy represents a philosophy of care in which the therapist facilitates the patient's own inherent ability to correct soft-tissue dysfunction.
    • Myofascial models were described in the osteopathic literature of the 1950s. Many other contemporary treatment approaches such as connective-tissue massage, Rolfing, strain and counterstrain, and soft-tissue mobilization use the same principles.
    • This is a highly interactive stretching technique that requires feedback from the patient's body to determine the direction, force, and duration of the stretch and to facilitate maximum relaxation of the tight or restricted tissues.
  • Walking has a less direct effect on the pelvic musculature but is a potent antidepressant. Walking regularly for 3 months has been shown to yield improvements in depression similar to those of antidepressant medications.
Previous
 
 
Contributor Information and Disclosures
Author

Martha K Terris, MD, FACS Professor, Department of Surgery, Section of Urology, Director, Urology Residency Training Program, Medical College of Georgia; Professor, Department of Physician Assistants, Medical College of Georgia School of Allied Health; Chief, Section of Urology, Augusta Veterans Affairs Medical Center

Martha K Terris, MD, FACS is a member of the following medical societies: American Cancer Society, Association of Women Surgeons, American Society of Clinical Oncology, Society of Urology Chairpersons and Program Directors, Society of Women in Urology, Society of Government Service Urologists, American College of Surgeons, American Institute of Ultrasound in Medicine, American Urological Association, New York Academy of Sciences, Society of University Urologists

Disclosure: Nothing to disclose.

Coauthor(s)

Christopher A Hathaway, MD, PhD Urologist, Yankton Medical Clinic

Christopher A Hathaway, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Urological Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Mark Jeffrey Noble, MD Consulting Staff, Urologic Institute, Cleveland Clinic Foundation

Mark Jeffrey Noble, MD is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, Kansas Medical Society, Sigma Xi, Society of University Urologists, SWOG

Disclosure: Nothing to disclose.

Chief Editor

Edward David Kim, MD, FACS Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center

Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, Tennessee Medical Association, Sexual Medicine Society of North America, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Repros.

Acknowledgements

Subbarao V Cherukuri, MD Consulting Staff, Department of Urology, St Joseph Regional Health Center

Subbarao V Cherukuri, MD is a member of the following medical societies: American Urological Association and Ohio State Medical Association

Disclosure: Nothing to disclose.

References
  1. Bogart LM, Suttorp MJ, Elliott MN, Clemens JQ, Berry SH. Validation of a quality-of-life scale for women with bladder pain syndrome/interstitial cystitis. Qual Life Res. 2011 Dec 7. [Medline].

  2. Ichim G, Fufezan O, Farcau M, Asavoaie C, Pop D, Staticescu S, et al. Clinical, imaging and cystometric findings of voiding dysfunction in children. Med Ultrason. 2011 Dec. 13(4):277-82. [Medline].

  3. Palleschi G, Carbone A, Ripoli A, Silvestri L, Petrozza V, Zanello PP, et al. A prospective study to evaluate the efficacy of cistiquer in improving lower urinary tract symptoms in females with urethral syndrome. Minerva Urol Nefrol. 2014 Jul 18. [Medline].

  4. Costantini E, Zucchi A, Del Zingaro M, Mearini L. Treatment of urethral syndrome: a prospective randomized study with Nd:YAG laser. Urol Int. 2006. 76(2):134-8. [Medline].

  5. Chen YL, Ha LF, Cen J, et al. [Comparative observation on therapeutic effects of electroacupuncture and manual acupuncture on female urethral syndrome]. Zhongguo Zhen Jiu. 2005 Jun. 25(6):425-6. [Medline].

  6. Cruz F, Silva C. Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update. Curr Opin Urol. 2004 Nov. 14(6):329-34. [Medline].

  7. Allen TD. Commentary on dysfunctional abnormalities of the urinary tract. Urol Clin North Am. 1980 Jun. 7(2):357-9. [Medline].

  8. Barrett DM, Wein AJ, Barrett DM, Wein AJ. Voiding dysfunction: Diagnosis, classification, and management. Gillenwater JY, Grayhack JT, Howards SS, eds. Adult and Pediatric Urology. 2nd ed. St. Louis, Mo: Mosby-Year Book; Vol 1: 1073-5.

  9. Bogart LM. Berry SH. Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J. Urol. Feb. 2007. 177(2):450-6. [Medline].

  10. Gerstenberg TC, Lykkegaard Nielsen M, Lindenberg J. Spastic striated external sphincter syndrome imitating recurrent urinary tract infection in females. Effect of long-term alpha- adrenergic blockade with phenoxybenzamine. Eur Urol. 1983. 9(2):87-92. [Medline].

  11. Kaur H, Arunkalaivanan AS. Urethral pain syndrome and its management. Obstet Gynecol Surv. May 2007. 62(5):348-51. [Medline].

  12. Lemack GE, Foster B, Zimmern PE. Urethral dilation in women: a questionnaire-based analysis of practice patterns. Urology. 1999 Jul. 54(1):37-43. [Medline].

  13. Schmidt RA. The urethral syndrome. Urol Clin North Am. 1985 May. 12(2):349-54. [Medline].

  14. Sugaya K, Nishijima S, Oda M, et al. Transabdominal vesical sonography of urethral syndrome and stress incontinence. Int J Urol. 2003 Jan. 10(1):36-42. [Medline].

  15. Voelzke BB, Breyer BN, McAninch JW. Blunt pediatric anterior and posterior urethral trauma: 32-year experience and outcomes. J Pediatr Urol. 2011 Jun 9. [Medline].

  16. Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol. 2001 Dec. 166(6):2226-31. [Medline].

  17. Wesselmann U, Burnett AL, Heinberg LJ. The urogenital and rectal pain syndromes. Pain. 1997 Dec. 73(3):269-94. [Medline].

  18. Zhang D, Xu Z. [Female prostatitis]. Zhonghua Nan Ke Xue. 2004 Jul. 10(7):547-8, 550. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.